The mechanism behind this functional switch from tumor suppressor to tumor promoter remains incompletely understood, but may be related to relative contributions of the canonical and non-canonical TGF-β signaling pathways, differences in intracellular coactivators and corepressors that alter SMAD complex DNA binding activity, or alterations in the tumor microenvironment [33]. Here, TGFB1 is linked to neoplasm.